Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the exclusive rights to commercialize NEXLETOL ® (bempedoic ...

Following similar deals in countries like the United States and the U.K., Canada is bolstering its stockpile of bird flu ...

In other avian flu developments, tests at the US Department of Agriculture (USDA) have confirmed the H5N1 strain in rats for ...

A third person in the U.S. has been hospitalized due to avian influenza and one person has died as the virus continues to spread among poultry and dairy cattle. Experts have their eyes on the ...

This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards. “We’ve been working with the administration and with Congress, and ...

Beneath these top-line numbers, the company reported a robust rebound in plasma collections, which was offset by weaker sales ...

A New Jersey pharmaceutical company has received a "conditional license" for its bird flu vaccine for use in chickens. The vaccine, developed by Zoetis, targets the H5N2 subtype of avian influenza ...

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

The U.S. Department of Agriculture last week issued a conditional license for an avian flu vaccine for use in chickens, amid an outbreak ravaging poultry flocks, contributing to the sky-high price ...